BioHorizons Launches Pro Zygoma Implant
Anchor. Adapt. Achieve with the new zygomatic implant for confidence in full-arch treatment.
BioHorizons’ new Pro Zygoma is designed to provide clinicians with a predictable, reliable solution for immediate placement in advanced full-arch procedures. The first implant in its remote anchorage portfolio, the new zygomatic implant is designed for use in severely resorbed maxillae. Clinicians can enhance the patient experience with less chair time and quicker recovery due to the graftless nature of zygomatic procedures with this new implant system.
Pro Zygoma offers several key features:
- Broad implant portfolio that includes 2 implant diameters to help clinicians confidently achieve primary stability
- A single prosthetic platform with a proven deep conical connection
- Expansive multi-unit abutment portfolio designed to accommodate diverse anatomical needs with angles ranging from 17 to 60 degrees
- One of the industry’s strongest materials for peace of mind in demanding cases that require high force
- Advanced cutting flutes evenly distribute force for optimized insertion torque
- Comprehensive surgical kit to provide clinicians with the instruments needed for any remote anchorage case
“We are excited to add the Pro Zygoma implant to our robust portfolio of predictable, reliable implant solutions,” Steve Boggan, president and CEO of BioHorizons, said in today’s press release. “This product launch allows us to offer more solutions to our customers, giving them a new, versatile option for providing life-changing treatment in dense zygomatic bone. And with Vulcan Custom Dental, we provide clinicians comprehensive support from treatment planning to restoration.”
The company plans to support the Pro Zygoma launch with zygomatic-specific education so clinicians can place the implant with confidence. Customers will also benefit from the same dedicated, knowledgeable support they are used to with the Customer Care team and their Territory Manager.
“Our goal for the Pro Zygoma system was to combine our clinically proven technologies with precision engineering to address the surgical demands of remote anchorage and advanced full-arch rehabilitation,” added John Bellanca, senior director of product and technology development for BioHorizons. “By leveraging a robust implant material, innovative body design and a deep conical connection, we’ve developed a solution that delivers exceptional stability, optimized load distribution and clinical success.”
For more information, visit biohorizons.com.
Comments